| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 4.255 | 12.370 | 9.200 | 11.098 | 3.508 | 3.235 | 2.000 |
| Total Income - EUR | - | - | - | 4.255 | 12.370 | 9.200 | 13.055 | 3.508 | 3.235 | 2.000 |
| Total Expenses - EUR | - | - | - | 1.050 | 7.988 | 8.535 | 9.271 | 5.560 | 2.018 | 1.780 |
| Gross Profit/Loss - EUR | - | - | - | 3.205 | 4.382 | 664 | 3.784 | -2.052 | 1.217 | 221 |
| Net Profit/Loss - EUR | - | - | - | 3.077 | 4.011 | 409 | 3.478 | -2.142 | 1.009 | 153 |
| Employees | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Ruxamed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 1.999 | 4.253 | 5.128 | 2.366 | 730 | 0 |
| Current Assets | - | - | - | 4.021 | 10.525 | 13.643 | 5.589 | 6.185 | 8.969 | 9.686 |
| Inventories | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | 731 | 0 | 207 | 2.227 | 5.705 | 8.714 | 0 |
| Cash | - | - | - | 3.291 | 10.525 | 13.437 | 3.362 | 481 | 256 | 9.684 |
| Shareholders Funds | - | - | - | 3.120 | 7.070 | 7.345 | 10.660 | 8.552 | 9.535 | 9.635 |
| Social Capital | - | - | - | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | 901 | 5.453 | 8.550 | 56 | 0 | 165 | 52 |
| Income in Advance | - | - | - | 0 | 0 | 2.001 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Ruxamed S.r.l.